This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Pharmaceutical therapeutic category forecasts: analysis of global top 10 therapeutic categories. New York: Lehman Brothers Global Equity Research, 2006
Incretin-targeting technologies for type 2 diabetes: dipeptidyl peptidase IV inhibitors and glucagon-like peptide-1 analogs. Pharmaceutical & Diagnostic Innovation. 2006; 4 (7): 3–7
Hypertension revolution or just hype?. First renin inhibitor close to market. Pharmaceutical & Diagnostic Innovation. 2006; 4 (4): 7–9
About this article
Cite this article
From Here to 2010. Pharmaceutical & Diagnostic Innovation 4, 8–11 (2006). https://doi.org/10.1007/BF03259661
- Chronic Obstructive Pulmonary Disease
- Insulin Glargine
- Cholesteryl Ester Transfer Protein